&Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.06M | Sell |
3,850
-2,272
| -37% | -$1.22M | 0.02% | 656 |
|
|
2025
Q1 | $3.91M | Buy |
6,122
+740
| +14% | +$472K | 0.04% | 348 |
|
|
2024
Q4 | $3.88M | Buy |
5,382
+3,440
| +177% | +$2.48M | 0.05% | 323 |
|
|
2024
Q3 | $2.04M | Buy |
1,942
+1,345
| +225% | +$1.41M | 0.04% | 363 |
|
|
2024
Q2 | $627K | Buy |
+597
| New | +$627K | 0.03% | 466 |
|